According to BBC News, the NHS has just approved a new immunotherapy that can delay type one diabetes in children and adults by roughly three years. The drug postpones the need for insulin therapy, marking the first such treatment available through the British healthcare system.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton